Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook

radionuclide therapy

  • You have access
    Intraarterial Peptide Receptor Radionuclide Therapy Using 90Y-DOTATOC for Hepatic Metastases of Neuroendocrine Tumors
    Courtney Lawhn-Heath, Nicholas Fidelman, Bryant Chee, Salma Jivan, Evan Armstrong, Li Zhang, Sheila Lindsay, Emily K. Bergsland and Thomas A. Hope
    Journal of Nuclear Medicine February 1, 2021, 62 (2) 221-227; DOI: https://doi.org/10.2967/jnumed.119.241273
  • Open Access
    Evaluation of safety and dosimetry of 177Lu DOTA-ZOL for therapy of bone metastases
    Rene Fernandez, Elisabeth Eppard, Wencke Lehnert, Luis David Jimenez-Franco, Cristian Soza-Ried, Matias Ceballos, Jessica Ribbeck, Andreas Kluge, Frank Roesch, Marian Meckel, Konstantin Zhernosekov, Vasko Kramer and Horacio Amaral
    Journal of Nuclear Medicine January 8, 2021, jnumed.120.255851; DOI: https://doi.org/10.2967/jnumed.120.255851
  • You have access
    Pharmacogenomics in Radionuclide Therapy: Impact on Response to Theranostics
    Andrew Scott and Lisa Bodei
    Journal of Nuclear Medicine December 31, 2020, jnumed.120.254995; DOI: https://doi.org/10.2967/jnumed.120.254995
  • You have access
    The Australasian Radiopharmaceutical Trials Network (ARTnet) – Clinical Trials, Evidence and Opportunity.
    Roslyn Francis, Dale Bailey, Michael S Hofman and Andrew Scott
    Journal of Nuclear Medicine December 31, 2020, jnumed.120.258152; DOI: https://doi.org/10.2967/jnumed.120.258152
  • You have access
    Comparative preclinical biodistribution, dosimetry and endoradiotherapy in mCRPC using 19F/177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T
    Nahid Yusufi, Alexander Wurzer, Michael Herz, Calogero D'Alessandria, Benedikt Feuerecker, Wolfgang Andreas Weber, Hans-Juergen Wester, Stephan G. Nekolla and Matthias Eiber
    Journal of Nuclear Medicine December 18, 2020, jnumed.120.254516; DOI: https://doi.org/10.2967/jnumed.120.254516
  • You have access
    A novel time-activity information sharing approach using nonlinear mixed models for patient-specific dosimetry with reduced imaging time points: application in SPECT/CT imaging post-177Lu-DOTATATE
    Theresa Devasia, Yuni K. Dewaraja, Kirk A Frey, Ka Kit Wong and Matthew J Schipper
    Journal of Nuclear Medicine December 18, 2020, jnumed.120.256255; DOI: https://doi.org/10.2967/jnumed.120.256255
  • You have access
    Overview of the First NRG-NCI Workshop on Dosimetry of Systemic Radiopharmaceutical Therapy (RPT)
    Emilie Roncali, Jacek Capala, Stanley H Benedict, Gamal Akabani, Bryan Bednarz, Vikram Bhadrasain, Wesley E. Bolch, Jeff Buchsbaum, Bonnie N. Clarke, Norman Coleman, Yuni K Dewaraja, Eric C. Frey, Michael Ghaly, Joseph Grudzinski, Robert F Hobbs, Roger W. Howell, John Laurence Humm, Charles Kunos, Steven M. Larson, Frank I Lin, Mark T. Madsen, Saed Mirzadeh, David L. Morse, Daniel A Pryma, George Sgouros, Sara St. James, Richard L. Wahl, Ying Xiao, Pat B. Zanzonico and Katherine B. Zukotynski
    Journal of Nuclear Medicine December 4, 2020, jnumed.120.255547; DOI: https://doi.org/10.2967/jnumed.120.255547
  • You have access
    Mechanisms of Resistance to Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy in a Mouse Model of Prostate Cancer
    Andreea D Stuparu, Joseph R Capri, Catherine Meyer, Thuc M Le, Susan L Evans-Axelsson, Kyle Current, Mark Lennox, Christine E. Mona, Wolfgang Peter Fendler, Jérémie Calais, Matthias Eiber, Magnus Dahlbom, Johannes Czernin, Caius G. Radu, Katharina Lückerath and Roger Slavik
    Journal of Nuclear Medicine December 4, 2020, jnumed.120.256263; DOI: https://doi.org/10.2967/jnumed.120.256263
  • You have access
    Preclinical evaluation of 213Bi-/225Ac-labeled low-molecular-weight compounds for radiopharmaceutical therapy of prostate cancer
    Sangeeta Ray, Ala Lisok, IL Minn, Anders Josefsson, Vivek Kumar, Mary Brummet, Srikanth Boinapally, Cory Brayton, Ronnie C Mease, George Sgouros, Robert F Hobbs and Martin G. Pomper
    Journal of Nuclear Medicine December 4, 2020, jnumed.120.256388; DOI: https://doi.org/10.2967/jnumed.120.256388
  • Open Access
    Phase I trial of 131I-GMIB-Anti-HER2-VHH1, a new promising candidate for HER2-targeted radionuclide therapy in breast cancer patients
    Matthias D'Huyvetter, Jens De Vos, Vicky Caveliers, Ilse Vaneycken, Johannes Heemskerk, Francois P. Duhoux, Christel Fontaine, Marian Vanhoeij, Albert D. Windhorst, Frank van der Aa, N. Harry Hendrikse, Jos L.E. Eersels, Hendrik Everaert, Pieterjan Gykiere, Nick Devoogdt, Geert Raes, Tony Lahoutte and Marleen Keyaerts
    Journal of Nuclear Medicine December 4, 2020, jnumed.120.255679; DOI: https://doi.org/10.2967/jnumed.120.255679

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire